UNSPSC 51273949: Thiopental/water

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN202. This VA Drug Class (CN202) classifies this compound as belonging to the group BARBITURIC ACID DERIVATIVE ANESTHETICS.

UNSPSC 51273949 Thiopental/water is a Commodity code that captures pharmaceutical products and related health supplies procured by state and local health agencies, counties, and cooperative purchasing alliances. Recent solicitations show state and local governments buying naloxone, drug deactivation systems, generic pharmaceuticals, and over-the-counter products through both direct county procurement and multi-state cooperative frameworks. The work spans manufacturer direct supply, wholesale distribution through authorized channels, and last-mile delivery to community health facilities and government agencies. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving multiple states including Oregon). These entities procure on behalf of health departments, community health buildings, and participating government facilities across their jurisdictions.

Recent activity concentrates in Florida, Texas, and the upper Midwest. Seminole County issued IFB 60459723LAS in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building and a July 26, 2023 response deadline. Texas HHS Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program, seeking information on direct contracting models outside traditional pharmacy benefit managers and wholesalers. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating states, with proposals due March 26, 2026 and contract performance effective July 1, 2026; the RFP requires manufacturers to supply through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., and weights evaluation 75 percent on price competitiveness, with a 3 percent administrative fee on all purchases.